Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
91136 trials found · Page 128 of 4557
-
Could ozempic help obese men become fathers?
Disease control Not yet recruitingWhy is this study being done? Obesity can harm men's fertility by lowering sperm quality and hormone levels, making it harder to have children. Weight loss through diet and exercise helps, but it's often hard to stick with. New medicines called GLP-1 receptor agonists, like semag…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Could ketamine replace morphine for kids in pain? major trial launches
Symptom relief Not yet recruitingPain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side eff…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Apr 26, 2026 20:02 UTC
-
Brain injury breakthrough? personalized blood pressure targets tested for first time
Disease control Not yet recruitingAfter severe traumatic brain injury, adequate blood flow to the brain is essential for recovery. This depends on arterial blood pressure, yet intensive care units apply fixed targets to all patients - treating every brain and patient the same. This study aims to change that. With…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated May 07, 2026 16:33 UTC
-
Engineered immune cells take on hard-to-treat cancers in early trial
Disease control Not yet recruitingOnly enrolling in Canada. The purpose of this study is to identify the highest dose of GCAR1, a chimeric antigen receptor (CAR-T) cell therapy, that can be tolerated without causing very severe side effects, and to see what effects GCAR1 has on selected cancers
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Engineered immune cells take aim at Hard-to-Treat lymphoma
Disease control Not yet recruitingThis is a Phase 1 interventional, single-arm, open- label, treatment study designed to evaluate the safety of h20.19 CAR T cells in patients with B-cell malignancies that have failed prior therapies.
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New synthetic implant offers hope for corneal edema patients with no transplant options
Disease control Not yet recruitingThe EndoArt® device is intended to treat patients with chronic corneal edema due to endothelial dysfunction, in whom prior multiple keratoplasty (EK/PK) have failed, and who are not reasonable candidates for any form of corneal transplant, including penetrating keratoplasty. The…
Phase: NA • Sponsor: Eye-yon Medical • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New Two-Drug attack targets Hard-to-Treat advanced cancers
Disease control Not yet recruitingThis is a single-arm, open-label, multicenter, Phase Ib/II clinical trial of CVL237 tablets in combination with serplulimab injection for the treatment of advanced solid tumors with PTEN loss or low expression
Phase: PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Apr 09, 2026 19:33 UTC
-
Bone-Shifting surgery could heal diabetic wounds and prevent amputations
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in patients with chronic ischemic and diabetic lower extremity ulcers. This study will assess wound healing outcomes and limb preservation in a population with limited…
Phase: NA • Sponsor: Biodynamik, Inc • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
New drug combo aims to keep lung cancer in check after chemoradiation
Disease control Not yet recruitingThis study is a prospective, single-arm, multicenter, exploratory clinical trial. It aims to evaluate the efficacy and safety of tislelizumab combined with nintedanib as consolidation therapy for patients with limited-stage small cell lung cancer after concurrent chemoradiotherap…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
New drug cocktail aims to boost stroke recovery
Disease control Not yet recruitingThis study is a multicentre, randomized, blinded-endpoint trial that aims to evaluate the efficacy and safety of human urinary kallidinogenase combined with reteplase intravenous thrombolysis in the treatment of acute ischemic stroke
Phase: NA • Sponsor: China-Japan Union Hospital • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
Experimental cell therapy targets tough leukemia in small early trial
Disease control Not yet recruitingThis study is an open-label, single-arm clinical trial designed to evaluate the safety and tolerability of QH103 cell infusion in subjects with CD19-positive R/R B-ALL.
Phase: PHASE1 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Targeted drug and radiation team up to fight aggressive kidney cancer
Disease control Not yet recruitingThis randomized, open-label, multicenter phase II study is designed to compare disitamab vedotin plus radiotherapy with gemcitabine plus carboplatin as adjuvant treatment in patients with HER2-expressing upper tract urothelial carcinoma after radical nephroureterectomy (RNU). Eli…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
New hope for kids with rare brain cancer: drug combo trial launches
Disease control Not yet recruitingThis is a multi-treatment arm study that will be conducted through the Pacific Pediatric Neuro-oncology Consortium (PNOC).The study will assess the safety and efficacy of novel therapies and combinatorial strategies for participants with recurrent or progressive ATRT.
Phase: PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Could a brain zapping device help veterans beat addiction?
Disease control Not yet recruitingThe purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 07, 2026 16:32 UTC
-
New telehealth program aims to bring HIV prevention to hidden trans communities
Prevention Not yet recruitingThe prevalence of HIV (Human Immunodeficiency Virus) and STIs (Sexually Transmitted Infections) is very high in the trans population, due to multifactorial components. The main risk factors for HIV in this population are unprotected receptive and insertive anal intercourse, mult…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated May 05, 2026 11:54 UTC
-
Magnetic brain zaps could lift severe depression that drugs Can't touch
Symptom relief Not yet recruitingThis study will evaluate the efficacy and safety of a theta burst stimulation (TBS) protocol of repetitive transcranial magnetic stimulation (rTMS) in adults with treatment-resistant depression. Participants will be randomized to either antidepressant treatment plus active rTMS T…
Phase: NA • Sponsor: Jung-Sun Lee • Aim: Symptom relief
Last updated May 07, 2026 16:31 UTC
-
AI and CT scans join forces to catch lung cancer early in latin america
Diagnosis Not yet recruitingProspective study to assess lung cancer screening with low dose CT scan (LDCT) in Latin America (LATAM) and prospectively evaluate chest-XRay analyzed with artificial intelligence (AI) using qXRin (QURE ai) at the initial visit correlating with the findins of the initial LDCT in …
Sponsor: Latin American Consortium for the Lung Cancer Research • Aim: Diagnosis
Last updated May 04, 2026 16:23 UTC
-
Blood test guides throat cancer therapy in new trial
Disease control Not yet recruitingThe purpose of this study is to assess risk for HPV driven oropharyngeal cancers by using HPV blood tests and clinical features (such as tumor stage and smoking status) to determine appropriate treatment to improve survival outcomes in participants with stage I, II, or III, HPV-a…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Steroid shield: new hope to prevent HIV treatment complications
Prevention Not yet recruitingThis study was a multicenter, open-label, randomized controlled clinical trial designed to evaluate the efficacy and safety of glucocorticoids in preventing paradoxical immune reconstitution inflammatory syndrome (IRIS) in patients with AIDS complicated by opportunistic infection…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated May 06, 2026 16:15 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control Recruiting nowGraft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), significantly affecting survival and quality of life. Acute GVHD (aGVHD) typically occurs within 100 days post-transplant, commonly involving skin, gastr…
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 07, 2026 16:30 UTC